Coronavirus

Private equity nears deal for Central Logic, Searchlight Capital collects more than $3bn for Fund III, Texas A&M hires ex-Texas Teachers exec as CIO

A private equity firm is close to buying Central Logic and Spectrum Equity wraps up a big fund.

Advantech and Vivo back Sinovac R&D's development of COVID-19 vaccine

Advantech Capital and Vivo Capital has invested $15 million in Sinovac R&D to accelerate development of a COVID-19 vaccine.

Remote dealmaking: CD&R sells naviHealth after less than two years, Francisco Partners' QGenda hits the auction block

Not all PE firms are postponing exits as evidenced by CD&R's sale of its stake in naviHealth.

Forescout to sue Advent for walking from deal agreement, CD&R reaps 2.5x on naviHealth exit, Secondaries deal flow picks up with 'highly motivated sellers'

A scuttled buyout gets hit with litigation and CD&R makes good coin from exiting naviHealth.

Forescout sues Advent, asserting MAE, to complete $1.9bn deal

Forescout has filed a complaint with the Delaware Court of Chancery asserting that affiliates of Advent have violated the terms of their merger agreement with Forescout.

Advent attempts to break $1.9bn Forescout Technologies deal, OMERS PE exec Hami Ebrahimi to join H&F portfolio company, Charlesbank invests $70m in Cyberbit

Advent stalls its take-private buyout of Forescout while Carlyle and GIC may be able to walk away from a deal with American Express GBT.